BioSpace News Archive

Business

HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer

HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare diseases, today announced the appointment of Brian Wamhoff , PhD, as interim chief executive officer.

August 25, 2022
·
4 min read
Drug Development

MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

Mind Medicine today announced first patient dosing in its Phase 2b dose-optimization trial of MM-120, a pharmaceutically optimized form of lysergic acid diethylamide (LSD), for the treatment of Generalized Anxiety Disorder (GAD).

August 25, 2022
·
5 min read
Business

BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update

BiondVax Pharmaceuticals Ltd. today published its financial results for the quarter ended June 30, 2022 and provided a business update.

August 25, 2022
·
9 min read
Pharm Country

Ordaōs Raises $5 Million in Seed to Accelerate Drug Design and Discovery

Ordaōs today announced the completion of $5M in seed financing to aid in new product development and expand partner acquisition efforts.

August 25, 2022
·
3 min read
Genetown

Stoke Therapeutics Enrolls First Patient in a Natural History Study of People Living with Autosomal Dominant Optic Atrophy (ADOA)

Stoke Therapeutics today announced enrollment of the first patient in a prospective natural history study of people ages 8 to 60 who are living with autosomal dominant optic atrophy (ADOA).

August 25, 2022
·
7 min read
Drug Development

Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies

Aptinyx Inc. today announced the completion of enrollment of 99 patients in the company’s ongoing Phase 2 study of NYX-458 in cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.

August 25, 2022
·
5 min read
Deals

Prestige Medical Imaging acquires MedServ Plus and XRV Healthcare

Prestige Medical Imaging announced today that it has completed acquisitions of MedServ Plus and XRV Healthcare to the PMI business platform.

August 25, 2022
·
3 min read
Business

Innovent Announced 2022 Interim Results and Business Updates

Innovent Biologics, Inc. announced 2022 interim results and major company updates.

August 25, 2022
·
11 min read
BioMidwest

Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA.

August 25, 2022
·
1 min read
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™

Longeveron Inc. today announced that the European Patent Office (EPO) has issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to methods to treat endothelial dysfunction.

August 25, 2022
·
6 min read